JP2023539361A5 - - Google Patents

Info

Publication number
JP2023539361A5
JP2023539361A5 JP2023514397A JP2023514397A JP2023539361A5 JP 2023539361 A5 JP2023539361 A5 JP 2023539361A5 JP 2023514397 A JP2023514397 A JP 2023514397A JP 2023514397 A JP2023514397 A JP 2023514397A JP 2023539361 A5 JP2023539361 A5 JP 2023539361A5
Authority
JP
Japan
Application number
JP2023514397A
Other languages
Japanese (ja)
Other versions
JP2023539361A (ja
JPWO2022051749A5 (https=
JP7824934B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/071330 external-priority patent/WO2022051749A1/en
Publication of JP2023539361A publication Critical patent/JP2023539361A/ja
Publication of JPWO2022051749A5 publication Critical patent/JPWO2022051749A5/ja
Publication of JP2023539361A5 publication Critical patent/JP2023539361A5/ja
Application granted granted Critical
Publication of JP7824934B2 publication Critical patent/JP7824934B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023514397A 2020-09-02 2021-08-31 操作されたナチュラルキラー細胞の増殖および細胞毒性の増強およびその使用 Active JP7824934B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063073671P 2020-09-02 2020-09-02
US63/073,671 2020-09-02
PCT/US2021/071330 WO2022051749A1 (en) 2020-09-02 2021-08-31 Enhanced expansion and cytotoxicity of engineered natural killer cells and uses thereof

Publications (4)

Publication Number Publication Date
JP2023539361A JP2023539361A (ja) 2023-09-13
JPWO2022051749A5 JPWO2022051749A5 (https=) 2024-09-10
JP2023539361A5 true JP2023539361A5 (https=) 2024-09-10
JP7824934B2 JP7824934B2 (ja) 2026-03-05

Family

ID=80492150

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023514397A Active JP7824934B2 (ja) 2020-09-02 2021-08-31 操作されたナチュラルキラー細胞の増殖および細胞毒性の増強およびその使用

Country Status (9)

Country Link
US (1) US20230265390A1 (https=)
EP (1) EP4204560A4 (https=)
JP (1) JP7824934B2 (https=)
KR (1) KR20230058167A (https=)
CN (1) CN116568805A (https=)
AU (1) AU2021337000A1 (https=)
CA (1) CA3191047A1 (https=)
IL (1) IL300903A (https=)
WO (1) WO2022051749A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015259877B2 (en) 2014-05-15 2021-02-25 National University Of Singapore Modified natural killer cells and uses thereof
KR102660336B1 (ko) 2017-03-27 2024-04-26 내셔널 유니버시티 오브 싱가포르 절단된 nkg2d 키메라 수용체 및 자연 살해 세포 면역요법에서의 그의 용도
AU2019219454A1 (en) 2018-02-09 2020-08-27 National University Of Singapore Activating chimeric receptors and uses thereof in natural killer cell immunotherapy
CN112055717B (zh) 2018-04-02 2024-04-26 新加坡国立大学 用在免疫细胞中表达的膜结合抗细胞因子非信号传导粘合剂中和人细胞因子
EP3844186A4 (en) 2018-08-29 2022-08-17 National University of Singapore METHOD OF SPECIFIC STIMULATION OF SURVIVAL AND EXPANSION OF GENETICALLY MODIFIED IMMUNE CELLS
US12590148B2 (en) 2018-11-26 2026-03-31 Nkarta, Inc. Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
AU2020232691B2 (en) 2019-03-05 2023-06-29 Nkarta, Inc. CD19-directed chimeric antigen receptors and uses thereof in immunotherapy
EP4649139A1 (en) * 2023-02-01 2025-11-19 Nkarta, Inc. Methods for expanding immune cells and related compositions and uses thereof
KR102669705B1 (ko) * 2023-02-24 2024-06-10 이엔셀 주식회사 제대혈 유래 자연 살해 세포의 확장배양방법
KR20240175366A (ko) * 2023-06-12 2024-12-20 한국화학연구원 Nk 세포의 증식 촉진 또는 활성화용 조성물 및 그의 용도
KR20250153112A (ko) * 2024-04-16 2025-10-24 주식회사 유씨아이테라퓨틱스 자연살해세포의 증폭 및 형질 도입 효율 증진용 피더 세포

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109844099B (zh) * 2016-07-25 2024-01-02 美国政府(由卫生和人类服务部的部长所代表) 产生经修饰的自然杀伤细胞的方法及使用方法
US10300089B2 (en) * 2016-11-08 2019-05-28 University Of Central Florida Research Foundation, Inc. Methods for high scale therapeutic production of memory NK cells
KR102746901B1 (ko) * 2017-03-03 2024-12-26 옵시디안 테라퓨틱스, 인크. Cd19 조성물 및 면역요법을 위한 방법
MX2019011570A (es) * 2017-03-27 2019-11-18 Nat Univ Singapore Lineas celulares estimuladoras para expansion y activacion ex vivo de celulas asesinas naturales.
JP7273421B2 (ja) * 2018-02-21 2023-05-15 ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム ナチュラルキラー細胞の活性化および拡大のための方法ならびにその使用
US12590148B2 (en) * 2018-11-26 2026-03-31 Nkarta, Inc. Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
MX2022001255A (es) * 2019-07-31 2022-05-10 Nkarta Inc Metodos y composiciones para la expansion y la citotoxicidad mejoradas de las celulas asesinas naturales.

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
JP2023539361A5 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)
BR102021016176A2 (https=)